Evaluation of Antibacterial and Antibiofilm Activity of Biogenic Silver Nanoparticles and Gentamicin Against Staphylococcus aureus Isolated from Caprine Mastitis
Article Sidebar
Main Article Content
Abstract
The goal of this study was to assess the antibacterial efficiency of biogenic silver nanoparticles (AgNPs) and gentamicin against Staphylococcus aureus that can form biofilms. The characterization of AgNPs was confirmed by the scanning electron microscope (SEM) which was spherical and homogenous in form, with a diameter between 25 and 45 nm. The X-ray diffraction (XRD) presented the size of AgNPs to be 50 nm. Energy dispersive spectroscopy (EDS) was used to examine the presence of elemental silver. The three-dimensional structure of silver nanoparticles was discovered using an atomic force microscope (AFM), with a diameter of 47.18 nm on average. The minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) of AgNPs and gentamicin against S. aureus isolated from caprine mastitis were determined using the microdilution assay. The checkerboard microdilution technique was utilized to inspect the synergistic antibacterial activity of AgNPs with gentamicin utilizing the fractional inhibitory concentration index (FICI). The antibiofilm capability of AgNPs was also investigated. The results indicate that AgNPs generated by biosynthesis are antibacterial against S. aureus. Moreover, AgNPs and gentamicin exhibit synergistic action. The study's findings suggest that biogenic AgNPs may act as anti-biofilm agents and treat mastitis caused by S. aureus. In conclusions biosynthesized AgNPs exhibit strong antibacterial and antibiofilm effectiveness and synergistic activity when combined with gentamicin.
Downloads
Article Details
How to Cite
References
Rainard P, Gitton C, Chaumeil T, Fassier T, Huau C, Riou M, et al. Host factors determine the evolution of infection with Staphylococcus aureus to gangrenous mastitis in goats. Vet Res. 2018; 49(1):1–17. https://doi.org/10.1186/s13567-018-0564-4
Angelidis AS, Komodromos D, Giannakou R, Arsenos G, Gelasakis AI, Kyritsi M, et al. Isolation and characterization of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) from milk of dairy goats under low-input farm management in Greece. Vet Microbiol. 2020; 247:108749. https://doi.org/10.1016/j.vetmic.2020.108749
Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018; 9(1):522–554. https://doi.org/10.1080/21505594.2017.1313372
Jiang Y, Geng M, Bai L. Targeting biofilms therapy: current research strategies and development hurdles. Microorganisms. 2020; 8(8):1222. https://doi.org/10.3390/microorganisms8081222
Malaekeh-Nikouei B, Bazzaz BSF, Mirhadi E, Tajani AS, Khameneh B. The role of nanotechnology in combating biofilm-based antibiotic resistance. J Drug Deliv Sci Technol. 2020; 101880. https://doi.org/10.1016/j.jddst.2020.101880
Salih ANA, Eesa MJ. Antibacterial activity of biosynthesized silver nanoparticles against Pseudomonas aeruginosa in vitro. Iraqi J. Vet. Med. 2017; 41(1):60–65. https://doi.org/10.30539/iraqijvm.v41i1.81
Wang J, Li J, Guo G, Wang Q, Tang J, Zhao Y, et al. Silver-nanoparticles-modified biomaterial surface resistant to Staphylococcus: new insight into the antimicrobial action of silver. Sci Rep. 2016; 6(1):1–16. https://doi.org/10.1038/srep32699
Murphy M, Ting K, Zhang X, Soo C, Zheng Z. Current development of silver nanoparticle preparation, investigation, and application in the field of medicine. J Nanomater. 2015; 2015. https://doi.org/10.1155/2015/696918
Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et al. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci. 2013;131(2):537–547. https://doi.org/10.1093/toxsci/kfs306
Institute C and LS. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. Clinical and Laboratory Standards Institute Wayne, PA; 2017.
Bär W, Bäde-Schumann U, Krebs A, Cromme L. Rapid method for detection of minimal bactericidal concentration of antibiotics. J Microbiol Methods. 2009; 77(1):85–89. https://doi.org/10.1016/j.mimet.2009.01.010
Owuama CI. Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) using a novel dilution tube method. African J Microbiol Res. 2017; 11(23):977–980. https://doi.org/10.5897/AJMR2017.8545
Humphries RM. Testing: broth microdilution checkerboard and broth macrodilution methods. Clin Microbiol Proced Handbook Washington, DC Am Soc Microbiol. 2016; 5:1–5. https://doi.org/10.1128/9781555818814.ch5.16
Botelho MG. Fractional inhibitory concentration index of combinations of antibacterial agents against cariogenic organisms. J Dent. 2000; 28(8): 565–570. https://doi.org/10.1016/S0300-5712(00)00039-7
Meletiadis J, Pournaras S, Roilides E, Walsh TJ. Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus. Antimicrob Agents Chemother. 2010;54(2):602–609. https://doi.org/10.1128/AAC.00999-09
Ruchi T, Sujata B, Anuradha D. Comparison of phenotypic methods for the detection of biofilm production in uro-pathogens in a tertiary care hospital in India. Int J Curr Microbiol App Sci. 2015; 4(9):840–849.
Singh P, Pandit S, Garnæs J, Tunjic S, Mokkapati VRSS, Sultan A, et al. Green synthesis of gold and silver nanoparticles from Cannabis sativa (industrial hemp) and their capacity for biofilm inhibition. Int J Nanomedicine. 2018; 13:3571. https://doi.org/10.2147/IJN.S157958
Greenwood D, Finch R, Davey P. Antimicrobial chemotherapy. Oxford university press, USA; 2007.
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009; 27(1):76–83. https://doi.org/10.1016/j.biotechadv.2008.09.002
Jiravova J, Tomankova KB, Harvanova M, Malina L, Malohlava J, Luhova L, et al. The effect of silver nanoparticles and silver ions on mammalian and plant cells in vitro. Food Chem Toxicol. 2016;96:50–61. https://doi.org/10.1016/j.fct.2016.07.015
Batarseh KI. Anomaly and correlation of killing in the therapeutic properties of silver (I) chelation with glutamic and tartaric acids. J Antimicrob Chemother. 2004; 54(2):546–548. https://doi.org/10.1093/jac/dkh349
Elbehiry A, Al‐Dubaib M, Marzouk E, Moussa I. Antibacterial effects and resistance induction of silver and gold nanoparticles against Staphylococcus aureus‐induced mastitis and the potential toxicity in rats. Microbiologyopen. 2019; 8(4):e00698. https://doi.org/10.1002/mbo3.698
Ipe DS, Kumar PT, Love RM, Hamlet SM. Silver nanoparticles at biocompatible dosage synergistically increases bacterial susceptibility to antibiotics. Front Microbiol. 2020; 11:1074. https://doi.org/10.3389/fmicb.2020.01074
Sharifi-Rad J, Hoseini‑Alfatemi SM, Sharifi-Rad M, Iriti M. Antimicrobial synergic effect of Allicin and silver nanoparticles on skin infection caused by methicillin resistant Staphylococcus aureus spp. Ann Med Health Sci Res. 2014; 4(6):863–868.
https://doi.org/10.4103/2141-9248.144883
Yuan Y-G, Peng Q-L, Gurunathan S. Effects of silver nanoparticles on multiple drug-resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa from mastitis-infected goats: an alternative approach for antimicrobial therapy. Int J Mol Sci. 2017; 18(3):569. https://doi.org/10.3390/ijms18030569
Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007; 73(6):1712–1720. https://doi.org/10.1128/AEM.02218-06
Barapatre A, Aadil KR, Jha H. Synergistic antibacterial and antibiofilm activity of silver nanoparticles biosynthesized by lignin-degrading fungus. Bioresour Bioprocess. 2016; 3(1):1–13. https://doi.org/10.1186/s40643-016-0083-y
Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine Nanotechnology, Biol Med. 2010; 6(1):103–109. https://doi.org/10.1016/j.nano.2009.04.006
Birla SS, Tiwari V, Gade AK, Ingle AP, Yadav AP, Rai MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol. 2009; 48(2):173–179. https://doi.org/10.1111/j.1472-765X.2008.02510.x
Smekalova M, Aragon V, Panacek A, Prucek R, Zboril R, Kvitek L. Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens. Vet J. 2016; 209:174–179. https://doi.org/10.1016/j.tvjl.2015.10.032
Van Dong P, Ha CH, Kasbohm J. Chemical synthesis and antibacterial activity of novel-shaped silver nanoparticles. Int Nano Lett. 2012; 2(1):1–9. https://doi.org/10.1186/2228-5326-2-9
Saha S, Malik MM, Qureshi MS. Study of synergistic effects of antibiotics and triangular shaped silver nanoparticles, synthesized using UV-light irradiation, on S. aureus and P. aeruginosa. Mater Today Proc. 2019; 18:920–927. https://doi.org/10.1016/j.matpr.2019.06.525
Arul Selvaraj RC, Rajendran M, Nagaiah HP. Re-potentiation of β-lactam antibiotic by synergistic combination with biogenic copper oxide nanocubes against biofilm forming multidrug-resistant bacteria. Molecules. 2019; 24(17):3055. https://doi.org/10.3390/molecules24173055
Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2: 2011 445–459. https://doi.org/10.4161/viru.2.5.17724
Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol. 2004; 186(6):1838–1850. https://doi.org/10.1128/JB.186.6.1838-1850.2004
Otto M. Staphylococcal biofilms. Bact biofilms. 2008: 207–28. https://doi.org/10.1007/978-3-540-75418-3_10
Faller M, Kohler T. The status of biofilms in penile implants. Microorganisms. 2017; 5(2):19. https://doi.org/10.3390/microorganisms5020019
Aldujaili NH, Alrufa MM, Sahib FH. Antibiofilm antibacterial and antioxidant activity of biosynthesized silver nanoparticles using pantoea agglomerans. J Pharm Sci Res. 2017; 9(7):1220.
Goswami SR, Sahareen T, Singh M, Kumar S. Role of biogenic silver nanoparticles in disruption of cell–cell adhesion in Staphylococcus aureus and Escherichia coli biofilm. J Ind Eng Chem. 2015; 26:73–80. https://doi.org/10.1016/j.jiec.2014.11.017
Martinez-Gutierrez F, Boegli L, Agostinho A, Sánchez EM, Bach H, Ruiz F, et al. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013; 29(6):651–660. https://doi.org/10.1080/08927014.2013.794225
Sharma VK, Sayes CM, Guo B, Pillai S, Parsons JG, Wang C, et al. Interactions between silver nanoparticles and other metal nanoparticles under environmentally relevant conditions: A review. Sci Total Environ. 2019; 653:1042–1051. https://doi.org/10.1016/j.scitotenv.2018.10.411
Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH. The antibacterial mechanism of silver nanoparticles and its application in dentistry. Int J Nanomedicine. 2020; 15:2555. https://doi.org/10.2147/IJN.S246764
Singh P, Pandit S, Beshay M, Mokkapati V, Garnaes J, Olsson ME, et al. Anti-biofilm effects of gold and silver nanoparticles synthesized by the Rhodiola rosea rhizome extracts. Artif cells, nanomedicine, Biotechnol. 2018; 46(sup3):S886–S899. https://doi.org/10.1080/21691401.2018.1518909
Applerot G, Lellouche J, Perkas N, Nitzan Y, Gedanken A, Banin E. ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and increase antibiotic susceptibility. Rsc Adv. 2012;2(6):2314–21. https://doi.org/10.1039/c2ra00602b
Sadekuzzaman M, Yang S, Mizan MFR, Ha SD. Current and recent advanced strategies for combating biofilms. Compr Rev Food Sci Food Saf. 2015; 14(4):491–509. https://doi.org/10.1111/1541-4337.12144